Predictive Oncology
POAI
POAI
18 hedge funds and large institutions have $300K invested in Predictive Oncology in 2024 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
1.54% less ownership
Funds ownership: 8.58% → 7.04% (-1.5%)
66% less capital invested
Capital invested by funds: $888K → $300K (-$588K)
Holders
18
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$35.7K | |
| 2 | +$33K | |
| 3 | +$26.7K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$14.2K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$13.2K |
Top Sellers
| 1 | -$308K | |
| 2 | -$75.1K | |
| 3 | -$52 | |
| 4 |
JPMorgan Chase & Co
New York
|
-$23 |
| 5 |
PP
PFS Partners
Mine Hill,
New Jersey
|
-$3 |